– Program provides accessible and affordable testing for pediatric epilepsy patients – – Genetic and clinical insights from test results to strengthen Invitae’s rare disease database – SAN FRANCISCO, July 22, 2024 /PRNewswire/ — Invitae (OTC: NVTAQ), a leading medical genetics company,…